| Term 
 | Definition 
 
        | Streptomycin  Isoniazid (Tubizid®) Ethambutol (Myambutol®) Rifampin (Rifadin®) Pyrazinamide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | No Brand Name     MOA: Bactericidal; Binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis   NOTE: Thompson said this is 2nd line treatment   Aminoglycoside |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tubizid®     MOA: Bactericidal; Inhibits lipid and nucleic acid synthesis     Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Myambutol®     MOA: Inhibits metabolite synthesis       Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rifadin®, Rimactane®     MOA: Inhibits DNA-dependent RNA polymerase       Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | No Brand Name     MOA: Converted to pyrazinoic acid in susceptible strains of Mycobacterium which lowers the pH of the environment     Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cycloserine (Seromycin® Pulvules) Para-amino salicyclic acid Ethionamide (Trecator-SC®) Ciprofloxacin (Cipro®) Levofloxacin (Levaquin®) Mofloxacin (Avelox®) Ofloxacin (Floxin®) Amikacin (Amikin®) Capreomycin (Capastat® sulfate) Linezolid (Zyvox®) Rifabitin (Ansamycin®) Rifapentine (Priftin®) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Seromycin® Pulvules     MOA: Bactericidal or bacteriostatic; Inhibits cell wall synthesis     Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 
        |         Para-amino salicyclic acid |  | Definition 
 
        | No Brand Name     MOA: Inhibits folic acid synthesis and inhibits synthesis of cell wall component, mycobactin, thus reducing iron uptake by M. tuberculosis     Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trecator-SC®     MOA: Inhibits peptide synthesis       Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cipro®     MOA: Bactericidal; inhibits DNA gyrase and topoisomerase IV      Fluoroqunolone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Levaquin®     MOA: Bactericidal; inhibits DNA gyrase and topoisomerase IV     Fluoroquinolone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Avelox®     MOA: Bactericidal; inhibits DNA gyrase and topoisomerase IV     Fluroquinolone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Floxin®     MOA: Bactericidal; inhibits DNA gyrase and topoisomerase IV     Fluroquinolone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amikin®     MOA: Bactericidal; Binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis     Aminoglycoside |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Capastat® Sulfate     MOA: A cyclic polypeptide antimicrobial        Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zyvox®     MOA: Binds to 50S ribosomal subunit, interfering with protein synthesis     Antibiotic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ansamycin®     MOA: Inhibits DNA-dependent RNA polymerase       Anti-tuberculosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Priftin®     MOA: Inhibits DNA-dependent RNA polymerase 
 
 
 Anti-tuberculosis |  | 
        |  |